<DOC>
	<DOCNO>NCT02775942</DOCNO>
	<brief_summary>A dose escalating study 3 different dose regimen study vaccine ( IPOVAC- POLYVAC-Vietnam ) license vaccine ( IMOVAC-Sanofi Pasteur- France ) conduct Vietnamese child , age 2 month assess safety immunogenicity . Two hundred forty child enrol place randomly 4 group ( 60 children/group ) , receive 3 dos vaccine subcutaneously , 4 week interval . Safety issue include immediate reaction site injection systemic reaction within 30 min administration , within 7 day dose , unexpected event occur within 30 day dose , SAE ( start dose 1 30 day dose 3 ) , blood cell count , urea , ALT , AST . Immunogenicity outcomes include seroconversion neutralising antibody vaccine serotypes .</brief_summary>
	<brief_title>Safety Immunogenicity IPOVAC Young Children</brief_title>
	<detailed_description>The use oral poliomyelitis vaccine ( OPV ) Vietnam expand immunisation program result successful eradication polio Vietnam . However due concern OPV-related poliomyelitis case occur worldwide , WHO recommend country gradually change inactivated polio vaccine ( IPV ) . In Vietnam , POLYVAC approve sponsored Ministry Science Technology produce IPV Japanese technology . The vaccine consist 3 serotypes ( Serotype 1,2 3 ) proven safety volunteer adult . In study , dose escalate study 3 different dose regimen study vaccine ( IPOVAC ) license vaccine ( IMOVAC-Sanofi Pasteur- France ) conduct Vietnamese child , age 2 month assess safety immunogenicity . Two hundred forty child enrol place randomly 4 group ( 60 children/group ) , receive 3 dos vaccine subcutaneously , 4 week interval . Safety issue evaluate include immediate reaction site injection systemic reaction within 30 min administration , within 7 day dose , unexpected event occur within 30 day dose , SAE ( start dose 1 30 day dose 3 ) , blood cell count , urea , ALT , AST . Seroconversion rate neutralise antibody vaccine serotypes assess .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<criteria>Children sex , 2 month age Full term baby ( &gt; =37 week ) Weight birth ( &gt; =2500gr ) Have vaccinate polio vaccine vaccine contain poliovirus component Not currently acute infection ( assessed via clinical check ask parents/care giver health history enrolment Parents/legal guardian agree participate child study sign inform consent . Currently chronic disease ( cardiovascular , liver spleen relate etc ) Use ( orally infection ) corticoid contain drug ( &gt; 1mg/kg dose ) Use immunocompromised treatment within 4 week enrolment Being immunocompromised autoimmune disease ( HIV , lupus ) history immunocompromised family history high fever Allergic vaccine component Fever ( &gt; 38oC ) within 3 day vaccination enrolment Malnourished ( 3rd level ) Blood disorder use vaccine licence 7 day enrolment study</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>